InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the full record of transactions filed by Payne Fletcher. Director active across 1 company, notably Aptose Biosciences Inc.. Cumulatively, 4 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €7k. History available since 19 September 2022. The latest transaction was disclosed on 19 January 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Payne Fletcher is a declarant linked to Aptose Biosciences Inc. on XNAS. The record shows 4 filings in total, and across the 4 recent filings available, purchases amount to EUR 6755 and sales to EUR 0, between 2022-09-21 and 2026-07-01, with the modal transaction nature shown as Disposition.